Table 3.
Crude and Multi-Adjusted Cox Regression Model for Survival After HCC Diagnosis
Variable | Categories | Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|---|---|
cHR | 95% CI | P-value | aHR | 95% CI | P-value | ||
Etiology | Non-viral vs viral | 1.216 | [1.052–1.406] | 0.0081 | 1.244 | [1.069–1.447] | 0.0047 |
Sex | Female vs Male | 0.838 | [0.779–0.901] | <10−3 | 0.97 | [0.899–1.046] | 0.4231 |
Year of diagnosis | 2014–2019 vs <2014 | 0.983 | [0.924–1.045] | 0.5754 | - | ||
Area of residence | Rural vs urban | 1.094 | [1.020–1.173] | 0.0116 | 0.986 | [0.917–1.059] | 0.6936 |
Age | 10y increase | 1.158 | [1.117–1.200] | <10−3 | 1.104 | [1.065–1.144] | <10−3 |
Hypertension | Yes vs no | 0.824 | [0.766–0.886] | <10−3 | 0.922 | [0.852–0.997] | 0.0418 |
Diabetes | Yes vs no | 0.907 | [0.847–0.972] | 0.0057 | 1.023 | [0.951–1.100] | 0.5414 |
BCLC stage at diagnosis | B vs 0/A | 1.85 | [1.649–2.076] | <10−3 | 1.822 | [1.621–2.048] | <10−3 |
C vs 0/A | 3.532 | [3.185–3.917] | 3.466 | [3.121–3.849] | |||
D vs 0/A | 5.685 | [5.139–6.289] | 5.657 | [5.102–6.273] |
Abbreviations: cHR, crude Hazard Ratio; aHR, adjusted Hazard Ratio; CI, confidence interval.